Search research articles
Contact Us
Filters
Showing results (81-90 of 133) with videos related to
Page
of 14
Sort By:
Breast Cancer Research and Treatment
|
November 1, 2024
Cardiovascular disease risk after breast cancer treatment in patients with a BRCA1/2 pathogenic variant
Lara Terra, Naomi B Boekel, Maartje H Hooning, et al.
NPJ Breast Cancer
|
March 23, 2021
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
Mathilde M M Almekinders, Michael Schaapveld, Bram Thijssen, et al.
The Journal of Pathology. Clinical Research
|
February 23, 2021
Variability in grading of ductal carcinoma in situ among an international group of pathologists
Maartje van Seijen, Katarzyna Jóźwiak, Sarah E Pinder, et al.
JNCI Cancer Spectrum
|
May 12, 2021
Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer
Tessa G Steenbruggen, Michael Schaapveld, Hugo M Horlings, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2018
Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors
Judy N Jacobse, Frances K Duane, Naomi B Boekel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2022
Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma
Simone de Vries, Miriam L Haaksma, Katarzyna Jóźwiak, et al.
European Journal of Heart Failure
|
November 8, 2019
Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years
Judy N Jacobse, Lars C Steggink, Gabe S Sonke, et al.
Journal of the National Cancer Institute
|
January 31, 2019
The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype
Iris Kramer, Michael Schaapveld, Hester S A Oldenburg, et al.
British Journal of Cancer
|
August 19, 2021
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast
Maartje van Seijen, Esther H Lips, Liping Fu, et al.
Blood
|
April 18, 2014
Risk of multiple primary malignancies following treatment of Hodgkin lymphoma
Anna M van Eggermond, Michael Schaapveld, Pieternella J Lugtenburg, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 133) with videos related to
Sort By:
Page
of 14
Breast Cancer Research and Treatment
|
November 1, 2024
Cardiovascular disease risk after breast cancer treatment in patients with a BRCA1/2 pathogenic variant
Lara Terra, Naomi B Boekel, Maartje H Hooning, et al.
NPJ Breast Cancer
|
March 23, 2021
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
Mathilde M M Almekinders, Michael Schaapveld, Bram Thijssen, et al.
The Journal of Pathology. Clinical Research
|
February 23, 2021
Variability in grading of ductal carcinoma in situ among an international group of pathologists
Maartje van Seijen, Katarzyna Jóźwiak, Sarah E Pinder, et al.
JNCI Cancer Spectrum
|
May 12, 2021
Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer
Tessa G Steenbruggen, Michael Schaapveld, Hugo M Horlings, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2018
Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors
Judy N Jacobse, Frances K Duane, Naomi B Boekel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2022
Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma
Simone de Vries, Miriam L Haaksma, Katarzyna Jóźwiak, et al.
European Journal of Heart Failure
|
November 8, 2019
Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years
Judy N Jacobse, Lars C Steggink, Gabe S Sonke, et al.
Journal of the National Cancer Institute
|
January 31, 2019
The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype
Iris Kramer, Michael Schaapveld, Hester S A Oldenburg, et al.
British Journal of Cancer
|
August 19, 2021
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast
Maartje van Seijen, Esther H Lips, Liping Fu, et al.
Blood
|
April 18, 2014
Risk of multiple primary malignancies following treatment of Hodgkin lymphoma
Anna M van Eggermond, Michael Schaapveld, Pieternella J Lugtenburg, et al.
Page
of 14